The importance of mosquito behavioural adaptations to malaria control in Africa ML Gatton, N Chitnis, T Churcher, MJ Donnelly, AC Ghani, HCJ Godfray, ... Evolution 67 (4), 1218-1230, 2013 | 408 | 2013 |
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. S Yeung, W Pongtavornpinyo, IM Hastings, AJ Mills, NJ White The American journal of tropical medicine and hygiene 71 (2 Supp), 179-186, 2004 | 274 | 2004 |
The evolution of drug–resistant malaria: the role of drug elimination half–life IM Hastings, WM Watkins, NJ White Philosophical Transactions of the Royal Society of London. Series B …, 2002 | 265 | 2002 |
Modelling a predictable disaster:: the rise and spread of drug-resistant malaria IM Hastings, U d’Alessandro Parasitology Today 16 (8), 340-347, 2000 | 213 | 2000 |
Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance SA Ward, EJP Sevene, IM Hastings, F Nosten, R McGready The Lancet infectious diseases 7 (2), 136-144, 2007 | 206 | 2007 |
Malaria and urbanization in sub-Saharan Africa MJ Donnelly, PJ McCall, C Lengeler, I Bates, U D'Alessandro, G Barnish, ... Malaria journal 4, 1-5, 2005 | 195 | 2005 |
The origins of antimalarial drug resistance IM Hastings TRENDS in Parasitology 20 (11), 512-518, 2004 | 158 | 2004 |
A model for the origins and spread of drug-resistant malaria IM Hastings Parasitology 115 (2), 133-141, 1997 | 156 | 1997 |
Mutation and selection within the individual SP Otto, IM Hastings Genetica 102, 507-524, 1998 | 149 | 1998 |
The evolution of multiple drug resistance in malaria parasites MJ Mackinnon, IM Hastings Transactions of the Royal Society of Tropical Medicine and Hygiene 92 (2 …, 1998 | 138 | 1998 |
PfCRT and the trans‐vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX PG Bray, M Mungthin, IM Hastings, GA Biagini, DK Saidu, V Lakshmanan, ... Molecular microbiology 62 (1), 238-251, 2006 | 131 | 2006 |
Tsetse control and Gambian sleeping sickness; implications for control strategy I Tirados, J Esterhuizen, V Kovacic, TNC Mangwiro, GA Vale, I Hastings, ... PLoS neglected tropical diseases 9 (8), e0003822, 2015 | 127 | 2015 |
Population genetic aspects of deleterious cytoplasmic genomes and their effect on the evolution of sexual reproduction IM Hastings Genetics Research 59 (3), 215-225, 1992 | 126 | 1992 |
Malaria and irrigated crops, Accra, Ghana E Klinkenberg, PJ McCall, IM Hastings, MD Wilson, FP Amerasinghe, ... Emerging infectious diseases 11 (8), 1290, 2005 | 125 | 2005 |
Intensity of malaria transmission and the evolution of drug resistance IM Hastings, WM Watkins Acta tropica 94 (3), 218-229, 2005 | 125 | 2005 |
Tolerance is the key to understanding antimalarial drug resistance IM Hastings, WM Watkins Trends in parasitology 22 (2), 71-77, 2006 | 117 | 2006 |
A research agenda for malaria eradication: modeling malERA Consultative Group on Modeling PLoS medicine 8 (1), e1000403, 2011 | 113 | 2011 |
Field, Genetic, and Modeling Approaches Show Strong Positive Selection Acting upon an Insecticide Resistance Mutation in Anopheles gambiae s.s. A Lynd, D Weetman, S Barbosa, A Egyir Yawson, S Mitchell, J Pinto, ... Molecular Biology and Evolution 27 (5), 1117-1125, 2010 | 112 | 2010 |
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies W Pongtavornpinyo, S Yeung, IM Hastings, AM Dondorp, NPJ Day, ... Malaria Journal 7, 1-12, 2008 | 101 | 2008 |
The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance IM Hastings, MJ Donnelly Drug Resistance Updates 8 (1-2), 43-50, 2005 | 100 | 2005 |